Cost Plus Drugs added the drugs to its portfolio Jan. 19, according to posts on X.
The company — which sells medications at their manufacturing price, a 15% markup and a $10 fee for shipping and handling — offers more than 4,000 drugs. Twenty are brand-name:
- Advair Diskus (fluticasone/salmeterol)
- Brenzavvy (bexagliflozin)
- CaroSpir (spironolactone)
- Climara (estradiol)
- Clomid (clomiphene citrate)
- Dexamethasone Intensol (dexamethasone)
- Duavee (conjugated estrogens/bazedoxifene)
- Estring (estradiol)
- GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
- Invokamet (canagliflozin-metformin HCl)
- Invokamet XR (canagliflozin-metformin HCl)
- Invokana (canagliflozin)
- Nitro-Bid (nitroglycerin)
- Premarin (conjugated estrogens)
- Premphase (conjugated estrogens/medroxyprogesterone)
- Prempro (conjugated estrogens/medroxyprogesterone)
- Promethegan (promethazine HCl)
- Tirosint (levothyroxine sodium)
- Yaz (drospirenone/ethinyl estradiol)
- Yusimry (adalimumab-aqvh)
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
